With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, ...

The nods allow Regeneron to better compete with Roche, which stormed the market in 2022 with Vabysmo. The Swiss drugmaker's ...

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...

Facing the fact that Lundbeck’s unexpected offer for Avadel Pharmaceuticals was sweeter, Alkermes has come back to the ...

Two months after Celltrion bought a U.S. manufacturing facility from Eli Lilly for roughly $330 million, the South Korean ...

The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...